Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,939 | 106 | 97.4% |
| Education | $52.14 | 4 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $387.69 | 17 | $0 (2024) |
| Novo Nordisk Inc | $245.85 | 13 | $0 (2019) |
| EISAI INC. | $183.18 | 11 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $180.69 | 10 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $139.15 | 9 | $0 (2018) |
| Amgen Inc. | $110.00 | 5 | $0 (2019) |
| Allergan Inc. | $97.48 | 7 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $95.20 | 5 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $88.31 | 5 | $0 (2019) |
| SANOFI PASTEUR INC. | $78.65 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $31.85 | 1 | PFIZER INC. ($31.85) |
| 2022 | $11.71 | 1 | Lilly USA, LLC ($11.71) |
| 2020 | $92.90 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($21.91) |
| 2019 | $333.21 | 18 | PFIZER INC. ($65.70) |
| 2018 | $613.61 | 34 | PFIZER INC. ($104.93) |
| 2017 | $907.66 | 51 | PFIZER INC. ($185.21) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/03/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $31.85 | General |
| Category: PAIN | ||||||
| 06/28/2022 | Lilly USA, LLC | — | Education | In-kind items and services | $11.71 | General |
| 10/05/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2020 | Bausch Health US, LLC | WELLBUTRIN (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: NEUROLOGY | ||||||
| 03/03/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Respiratory | ||||||
| 02/19/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: RESPIRATORY | ||||||
| 01/28/2020 | SANOFI PASTEUR INC. | ADACEL (Biological), FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Vaccines | ||||||
| 12/10/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/03/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Neuroscience | ||||||
| 11/26/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Obesity | ||||||
| 11/05/2019 | PFIZER INC. | CHANTIX (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/14/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.62 | General |
| Category: Cardiovascular | ||||||
| 08/19/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: UROLOGY | ||||||
| 07/29/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/29/2019 | Nalpropion Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: OBESITY | ||||||
| 07/22/2019 | EISAI INC. | Belviq (Drug) | Food and Beverage | Cash or cash equivalent | $19.06 | General |
| Category: Nutrition and Weight Loss | ||||||
| 06/17/2019 | EISAI INC. | Belviq (Drug) | Food and Beverage | Cash or cash equivalent | $16.66 | General |
| Category: Nutrition and Weight Loss | ||||||
| 06/10/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/04/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Obesity | ||||||
| 05/07/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Respiratory | ||||||
| 04/30/2019 | EISAI INC. | Belviq (Drug) | Food and Beverage | Cash or cash equivalent | $16.75 | General |
| Category: Nutrition and Weight Loss | ||||||
| 03/21/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Virology & Specialty Care | ||||||
| 03/19/2019 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT (Drug), ADACEL, FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: VACCINES | ||||||
| 01/29/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 751 | 1,216 | $171,407 | $84,001 |
| 2022 | 10 | 806 | 1,292 | $158,919 | $77,179 |
| 2021 | 10 | 744 | 1,171 | $153,414 | $71,277 |
| 2020 | 10 | 671 | 1,116 | $131,977 | $55,063 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 171 | 483 | $95,634 | $45,041 | 47.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 99 | 99 | $21,835 | $13,250 | 60.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 92 | $11,684 | $5,965 | 51.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 72 | 72 | $7,200 | $5,179 | 71.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 15 | $10,230 | $3,434 | 33.6% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 20 | 20 | $5,000 | $2,860 | 57.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 73 | 73 | $3,212 | $2,359 | 73.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 150 | 269 | $6,187 | $2,260 | 36.5% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 13 | 13 | $3,250 | $1,670 | 51.4% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 33 | 33 | $2,475 | $1,422 | 57.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 41 | 47 | $4,700 | $559.82 | 11.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 167 | 437 | $86,548 | $40,921 | 47.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 100 | 100 | $22,000 | $13,729 | 62.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 103 | 178 | $22,606 | $12,247 | 54.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 72 | 72 | $7,200 | $4,935 | 68.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 75 | 75 | $3,300 | $2,327 | 70.5% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 21 | 21 | $1,260 | $857.43 | 68.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 160 | 287 | $6,601 | $849.54 | 12.9% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 15 | 18 | $3,204 | $579.60 | 18.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 39 | 44 | $4,400 | $526.99 | 12.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 54 | 60 | $1,800 | $206.15 | 11.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 154 | 412 | $81,576 | $39,109 | 47.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 95 | 95 | $20,900 | $13,401 | 64.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 85 | 119 | $15,113 | $7,150 | 47.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 71 | 72 | $7,200 | $4,686 | 65.1% |
About Dr. Roman Mandzij, DO
Dr. Roman Mandzij, DO is a Internal Medicine healthcare provider based in Winnetka, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841239902.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roman Mandzij, DO has received a total of $1,991 in payments from pharmaceutical and medical device companies, with $31.85 received in 2024. These payments were reported across 110 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($1,939).
As a Medicare-enrolled provider, Mandzij has provided services to 2,972 Medicare beneficiaries, totaling 4,795 services with total Medicare billing of $287,520. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Winnetka, IL
- Active Since 06/05/2006
- Last Updated 12/12/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841239902
Products in Payments
- Saxenda (Drug) $186.72
- Belviq (Drug) $183.18
- CHANTIX (Drug) $162.85
- ELIQUIS (Drug) $155.35
- SYMBICORT (Drug) $132.50
- Prolia (Biological) $91.87
- VIAGRA (Drug) $91.36
- TOUJEO (Drug) $82.78
- Victoza (Drug) $59.13
- XIFAXAN (Drug) $53.87
- LINZESS (Drug) $42.68
- FLUZONE HIGH-DOSE (Drug) $40.74
- VIBERZI (Drug) $40.12
- STIOLTO (Drug) $37.54
- SPIRIVA RESPIMAT (Drug) $35.98
- RELISTOR (Drug) $34.44
- CONTRAVE (Drug) $34.19
- MYRBETRIQ (Drug) $33.80
- VYVANSE (Drug) $32.04
- SOLIQUA (Drug) $31.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Winnetka
Dr. Kristi Tough Desapri, M.d, M.D
Internal Medicine — Payments: $328,189
Dr. Alfred Torrence, Md, MD
Internal Medicine — Payments: $3,090
Claire Kenneally, M.d, M.D
Internal Medicine — Payments: $3,024
David Donnersberger, Md, MD
Internal Medicine — Payments: $2,336
Dr. Robin Wind, M.d, M.D
Internal Medicine — Payments: $2,236
Robert Magrisso, Md, MD
Internal Medicine — Payments: $1,889